|
⚲
|
| Keyboard |
| Eikon Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001861123 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001861123] | |
| 10-Q | [0001861123] | |
| 3 | [0001861123] | |
| 4 | [0001861123] | |
| 8-K | [0001861123] | |
| D | [0001861123] | |
| SC 13D | [0001861123] | |
| SC 13G | [0001861123] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Eikon Therapeutics Inc EIKN
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 67,044 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 87,157 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 25,873 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 25,873 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 268,176 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 67,044 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 134,088 | $0.00 | |
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 10,467,526 | ||
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 2,502,252 | ||
|
Eikon Therapeutics Inc EIKN
Series B Preferred Stock · derivative
|
2026-02-06 | Conversion | 796,380 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 2,155,765 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 1,151,540 | ||
|
Eikon Therapeutics Inc EIKN
Common Stock
|
2026-02-06 | Conversion | 2,387,705 | ||
|
Eikon Therapeutics Inc EIKN
Series A Preferred Stock · derivative
|
2026-02-06 | Conversion | 10,000,000 | ||
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 7,807,026 | ||
|
Eikon Therapeutics Inc EIKN
Series A-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 2,502,252 | ||
|
Eikon Therapeutics Inc EIKN
Series B Preferred Stock · derivative
|
2026-02-06 | Conversion | 796,380 | ||
|
Eikon Therapeutics Inc EIKN
Series B Preferred Stock · derivative
|
2026-02-06 | Conversion | 530,920 | ||
|
Eikon Therapeutics Inc EIKN
Series B-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 5,289,322 | ||
|
Eikon Therapeutics Inc EIKN
Series B-1 Preferred Stock · derivative
|
2026-02-06 | Conversion | 3,526,215 | ||
| showing 20 of 87 most recent transactions | |||||